Inpharamo, a subsidiary of Semicrol, has signed a collaboration agreement to support the entry of the Swiss company, Clinerion. The partnership is dedicated to optimizing the identification of patients who are candidates for participation in clinical trials in Mexico.
For more information, click here.
‘Hypothesis-Free’: Getting Proactive About Signal Detection
December 5th 2023Elizabeth Smalley, director of product management, data, and analytics at ArisGlobal speaks about her work at the software company in supporting the efforts of life sciences clinical and pharmacovigilance teams in signal detection.